Valmie Resources, Inc.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, QUCCF has a market cap of 295.12B. Regarding current trading prices, VMRI is priced at $0.00, while QUCCF trades at $12.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas QUCCF's P/E ratio is 10.21. In terms of profitability, VMRI's ROE is +0.00%, compared to QUCCF's ROE of +0.31%. Regarding short-term risk, VMRI is more volatile compared to QUCCF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, ANET has a market cap of 108.66B. Regarding current trading prices, VMRI is priced at $0.00, while ANET trades at $86.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas ANET's P/E ratio is 36.51. In terms of profitability, VMRI's ROE is +0.00%, compared to ANET's ROE of +0.32%. Regarding short-term risk, VMRI is more volatile compared to ANET. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, DELL has a market cap of 66.96B. Regarding current trading prices, VMRI is priced at $0.00, while DELL trades at $95.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas DELL's P/E ratio is 15.04. In terms of profitability, VMRI's ROE is +0.00%, compared to DELL's ROE of -1.88%. Regarding short-term risk, VMRI is more volatile compared to DELL. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CAJFF has a market cap of 30.16B. Regarding current trading prices, VMRI is priced at $0.00, while CAJFF trades at $32.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CAJFF's P/E ratio is 28.62. In terms of profitability, VMRI's ROE is +0.00%, compared to CAJFF's ROE of +0.03%. Regarding short-term risk, VMRI is more volatile compared to CAJFF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CAJPY has a market cap of 29.65B. Regarding current trading prices, VMRI is priced at $0.00, while CAJPY trades at $31.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CAJPY's P/E ratio is 27.72. In terms of profitability, VMRI's ROE is +0.00%, compared to CAJPY's ROE of +0.05%. Regarding short-term risk, VMRI is more volatile compared to CAJPY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, HPQ has a market cap of 24.94B. Regarding current trading prices, VMRI is priced at $0.00, while HPQ trades at $26.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas HPQ's P/E ratio is 9.52. In terms of profitability, VMRI's ROE is +0.00%, compared to HPQ's ROE of -2.31%. Regarding short-term risk, VMRI is more volatile compared to HPQ. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CAJ has a market cap of 21.97B. Regarding current trading prices, VMRI is priced at $0.00, while CAJ trades at $21.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CAJ's P/E ratio is 12.43. In terms of profitability, VMRI's ROE is +0.00%, compared to CAJ's ROE of +0.08%. Regarding short-term risk, VMRI is more volatile compared to CAJ. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, STX has a market cap of 20.31B. Regarding current trading prices, VMRI is priced at $0.00, while STX trades at $95.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas STX's P/E ratio is 13.77. In terms of profitability, VMRI's ROE is +0.00%, compared to STX's ROE of -1.27%. Regarding short-term risk, VMRI is more volatile compared to STX. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, NTAP has a market cap of 19.29B. Regarding current trading prices, VMRI is priced at $0.00, while NTAP trades at $93.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas NTAP's P/E ratio is 17.31. In terms of profitability, VMRI's ROE is +0.00%, compared to NTAP's ROE of +1.15%. Regarding short-term risk, VMRI is more volatile compared to NTAP. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SMCI has a market cap of 18.93B. Regarding current trading prices, VMRI is priced at $0.00, while SMCI trades at $31.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SMCI's P/E ratio is 13.87. In terms of profitability, VMRI's ROE is +0.00%, compared to SMCI's ROE of +0.25%. Regarding short-term risk, VMRI is more volatile compared to SMCI. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, PSTG has a market cap of 15.93B. Regarding current trading prices, VMRI is priced at $0.00, while PSTG trades at $48.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas PSTG's P/E ratio is 157.10. In terms of profitability, VMRI's ROE is +0.00%, compared to PSTG's ROE of +0.08%. Regarding short-term risk, VMRI is more volatile compared to PSTG. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, WDC has a market cap of 15.38B. Regarding current trading prices, VMRI is priced at $0.00, while WDC trades at $44.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas WDC's P/E ratio is 15.10. In terms of profitability, VMRI's ROE is +0.00%, compared to WDC's ROE of +0.16%. Regarding short-term risk, VMRI is more volatile compared to WDC. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, LNVGF has a market cap of 15.03B. Regarding current trading prices, VMRI is priced at $0.00, while LNVGF trades at $1.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas LNVGF's P/E ratio is 13.47. In terms of profitability, VMRI's ROE is +0.00%, compared to LNVGF's ROE of +0.29%. Regarding short-term risk, VMRI is more volatile compared to LNVGF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, LNVGY has a market cap of 14.91B. Regarding current trading prices, VMRI is priced at $0.00, while LNVGY trades at $23.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas LNVGY's P/E ratio is 12.76. In terms of profitability, VMRI's ROE is +0.00%, compared to LNVGY's ROE of +0.29%. Regarding short-term risk, VMRI is more volatile compared to LNVGY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, ASUUY has a market cap of 14.66B. Regarding current trading prices, VMRI is priced at $0.00, while ASUUY trades at $98.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas ASUUY's P/E ratio is 13.73. In terms of profitability, VMRI's ROE is +0.00%, compared to ASUUY's ROE of +0.12%. Regarding short-term risk, VMRI is more volatile compared to ASUUY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, LOGI has a market cap of 11.97B. Regarding current trading prices, VMRI is priced at $0.00, while LOGI trades at $80.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas LOGI's P/E ratio is 19.52. In terms of profitability, VMRI's ROE is +0.00%, compared to LOGI's ROE of +0.30%. Regarding short-term risk, VMRI is more volatile compared to LOGI. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, IONQ-WT has a market cap of 7.69B. Regarding current trading prices, VMRI is priced at $0.00, while IONQ-WT trades at $19.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas IONQ-WT's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to IONQ-WT's ROE of -0.75%. Regarding short-term risk, VMRI is more volatile compared to IONQ-WT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, IONQ has a market cap of 7.61B. Regarding current trading prices, VMRI is priced at $0.00, while IONQ trades at $31.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas IONQ's P/E ratio is -20.04. In terms of profitability, VMRI's ROE is +0.00%, compared to IONQ's ROE of -0.75%. Regarding short-term risk, VMRI is more volatile compared to IONQ. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SNDKV has a market cap of 7.25B. Regarding current trading prices, VMRI is priced at $0.00, while SNDKV trades at $50.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SNDKV's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to SNDKV's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to SNDKV. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SEKEY has a market cap of 4.39B. Regarding current trading prices, VMRI is priced at $0.00, while SEKEY trades at $6.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SEKEY's P/E ratio is 11.47. In terms of profitability, VMRI's ROE is +0.00%, compared to SEKEY's ROE of +0.05%. Regarding short-term risk, VMRI is more volatile compared to SEKEY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SEKEF has a market cap of 4.15B. Regarding current trading prices, VMRI is priced at $0.00, while SEKEF trades at $12.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SEKEF's P/E ratio is 11.07. In terms of profitability, VMRI's ROE is +0.00%, compared to SEKEF's ROE of +0.05%. Regarding short-term risk, VMRI is more volatile compared to SEKEF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, ACEYY has a market cap of 3.42B. Regarding current trading prices, VMRI is priced at $0.00, while ACEYY trades at $5.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas ACEYY's P/E ratio is 34.27. In terms of profitability, VMRI's ROE is +0.00%, compared to ACEYY's ROE of +0.07%. Regarding short-term risk, VMRI is more volatile compared to ACEYY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, QBTS has a market cap of 3.19B. Regarding current trading prices, VMRI is priced at $0.00, while QBTS trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas QBTS's P/E ratio is -14.79. In terms of profitability, VMRI's ROE is +0.00%, compared to QBTS's ROE of +45.17%. Regarding short-term risk, VMRI is more volatile compared to QBTS. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, RGTI has a market cap of 3.04B. Regarding current trading prices, VMRI is priced at $0.00, while RGTI trades at $10.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas RGTI's P/E ratio is -9.71. In terms of profitability, VMRI's ROE is +0.00%, compared to RGTI's ROE of -1.65%. Regarding short-term risk, VMRI is more volatile compared to RGTI. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, RGTIW has a market cap of 2.97B. Regarding current trading prices, VMRI is priced at $0.00, while RGTIW trades at $3.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas RGTIW's P/E ratio is -1.99. In terms of profitability, VMRI's ROE is +0.00%, compared to RGTIW's ROE of -1.65%. Regarding short-term risk, VMRI is more volatile compared to RGTIW. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, FXCOF has a market cap of 2.49B. Regarding current trading prices, VMRI is priced at $0.00, while FXCOF trades at $1.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas FXCOF's P/E ratio is 17.60. In terms of profitability, VMRI's ROE is +0.00%, compared to FXCOF's ROE of +0.03%. Regarding short-term risk, VMRI is more volatile compared to FXCOF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, QBTS-WT has a market cap of 2.14B. Regarding current trading prices, VMRI is priced at $0.00, while QBTS-WT trades at $6.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas QBTS-WT's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to QBTS-WT's ROE of +45.17%. Regarding short-term risk, VMRI is more volatile compared to QBTS-WT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, TSHTY has a market cap of 1.94B. Regarding current trading prices, VMRI is priced at $0.00, while TSHTY trades at $9.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas TSHTY's P/E ratio is 3.97. In terms of profitability, VMRI's ROE is +0.00%, compared to TSHTY's ROE of -0.06%. Regarding short-term risk, VMRI is more volatile compared to TSHTY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, LGNRF has a market cap of 1.64B. Regarding current trading prices, VMRI is priced at $0.00, while LGNRF trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas LGNRF's P/E ratio is -2.79. In terms of profitability, VMRI's ROE is +0.00%, compared to LGNRF's ROE of +0.00%. Regarding short-term risk, VMRI is more volatile compared to LGNRF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CRCT has a market cap of 1.30B. Regarding current trading prices, VMRI is priced at $0.00, while CRCT trades at $6.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CRCT's P/E ratio is 19.77. In terms of profitability, VMRI's ROE is +0.00%, compared to CRCT's ROE of +0.13%. Regarding short-term risk, VMRI is more volatile compared to CRCT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, QUBT has a market cap of 1.18B. Regarding current trading prices, VMRI is priced at $0.00, while QUBT trades at $8.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas QUBT's P/E ratio is -11.77. In terms of profitability, VMRI's ROE is +0.00%, compared to QUBT's ROE of -0.86%. Regarding short-term risk, VMRI is more volatile compared to QUBT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, MKFG-WT has a market cap of 999.50M. Regarding current trading prices, VMRI is priced at $0.00, while MKFG-WT trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas MKFG-WT's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to MKFG-WT's ROE of -0.80%. Regarding short-term risk, VMRI is more volatile compared to MKFG-WT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CRSR has a market cap of 798.93M. Regarding current trading prices, VMRI is priced at $0.00, while CRSR trades at $7.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CRSR's P/E ratio is -7.95. In terms of profitability, VMRI's ROE is +0.00%, compared to CRSR's ROE of -0.15%. Regarding short-term risk, VMRI is more volatile compared to CRSR. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SSYS has a market cap of 789.61M. Regarding current trading prices, VMRI is priced at $0.00, while SSYS trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SSYS's P/E ratio is -6.47. In terms of profitability, VMRI's ROE is +0.00%, compared to SSYS's ROE of -0.14%. Regarding short-term risk, VMRI is more volatile compared to SSYS. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, DRSHF has a market cap of 756.09M. Regarding current trading prices, VMRI is priced at $0.00, while DRSHF trades at $0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas DRSHF's P/E ratio is 86.50. In terms of profitability, VMRI's ROE is +0.00%, compared to DRSHF's ROE of +0.04%. Regarding short-term risk, VMRI is more volatile compared to DRSHF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, WACMF has a market cap of 585.63M. Regarding current trading prices, VMRI is priced at $0.00, while WACMF trades at $4.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas WACMF's P/E ratio is 16.84. In terms of profitability, VMRI's ROE is +0.00%, compared to WACMF's ROE of +0.09%. Regarding short-term risk, VMRI is more volatile compared to WACMF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, JFEYF has a market cap of 584.79M. Regarding current trading prices, VMRI is priced at $0.00, while JFEYF trades at $18.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas JFEYF's P/E ratio is 9.96. In terms of profitability, VMRI's ROE is +0.00%, compared to JFEYF's ROE of +0.11%. Regarding short-term risk, VMRI is more volatile compared to JFEYF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, RCAT has a market cap of 536.75M. Regarding current trading prices, VMRI is priced at $0.00, while RCAT trades at $5.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas RCAT's P/E ratio is -11.63. In terms of profitability, VMRI's ROE is +0.00%, compared to RCAT's ROE of -1.00%. Regarding short-term risk, VMRI is more volatile compared to RCAT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, WACMY has a market cap of 524.60M. Regarding current trading prices, VMRI is priced at $0.00, while WACMY trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas WACMY's P/E ratio is 13.96. In terms of profitability, VMRI's ROE is +0.00%, compared to WACMY's ROE of +0.09%. Regarding short-term risk, VMRI is more volatile compared to WACMY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, PCPPF has a market cap of 384.03M. Regarding current trading prices, VMRI is priced at $0.00, while PCPPF trades at $0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas PCPPF's P/E ratio is 8.33. In terms of profitability, VMRI's ROE is +0.00%, compared to PCPPF's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to PCPPF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, DDD has a market cap of 320.56M. Regarding current trading prices, VMRI is priced at $0.00, while DDD trades at $2.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas DDD's P/E ratio is -1.22. In terms of profitability, VMRI's ROE is +0.00%, compared to DDD's ROE of -0.86%. Regarding short-term risk, VMRI is more volatile compared to DDD. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, NNDM has a market cap of 257.06M. Regarding current trading prices, VMRI is priced at $0.00, while NNDM trades at $1.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas NNDM's P/E ratio is -3.70. In terms of profitability, VMRI's ROE is +0.00%, compared to NNDM's ROE of -0.10%. Regarding short-term risk, VMRI is more volatile compared to NNDM. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CAN has a market cap of 214.73M. Regarding current trading prices, VMRI is priced at $0.00, while CAN trades at $0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CAN's P/E ratio is -0.81. In terms of profitability, VMRI's ROE is +0.00%, compared to CAN's ROE of -0.73%. Regarding short-term risk, VMRI is more volatile compared to CAN. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, ZSPC has a market cap of 167.26M. Regarding current trading prices, VMRI is priced at $0.00, while ZSPC trades at $7.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas ZSPC's P/E ratio is 7.11. In terms of profitability, VMRI's ROE is +0.00%, compared to ZSPC's ROE of +0.89%. Regarding short-term risk, VMRI is more volatile compared to ZSPC. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, TIO has a market cap of 166.95M. Regarding current trading prices, VMRI is priced at $0.00, while TIO trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas TIO's P/E ratio is 1.53. In terms of profitability, VMRI's ROE is +0.00%, compared to TIO's ROE of -0.06%. Regarding short-term risk, VMRI is more volatile compared to TIO. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, DM has a market cap of 165.37M. Regarding current trading prices, VMRI is priced at $0.00, while DM trades at $4.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas DM's P/E ratio is -0.44. In terms of profitability, VMRI's ROE is +0.00%, compared to DM's ROE of -2.39%. Regarding short-term risk, VMRI is more volatile compared to DM. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, AOMUF has a market cap of 153.76M. Regarding current trading prices, VMRI is priced at $0.00, while AOMUF trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas AOMUF's P/E ratio is -10.62. In terms of profitability, VMRI's ROE is +0.00%, compared to AOMUF's ROE of -0.09%. Regarding short-term risk, VMRI is more volatile compared to AOMUF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, MICT has a market cap of 118.01M. Regarding current trading prices, VMRI is priced at $0.00, while MICT trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas MICT's P/E ratio is -2.99. In terms of profitability, VMRI's ROE is +0.00%, compared to MICT's ROE of -40.50%. Regarding short-term risk, VMRI is more volatile compared to MICT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, MKFG has a market cap of 98.34M. Regarding current trading prices, VMRI is priced at $0.00, while MKFG trades at $4.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas MKFG's P/E ratio is -1.12. In terms of profitability, VMRI's ROE is +0.00%, compared to MKFG's ROE of -0.80%. Regarding short-term risk, VMRI is more volatile compared to MKFG. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SCTQ has a market cap of 98.07M. Regarding current trading prices, VMRI is priced at $0.00, while SCTQ trades at $2.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SCTQ's P/E ratio is 15.64. In terms of profitability, VMRI's ROE is +0.00%, compared to SCTQ's ROE of +0.20%. Regarding short-term risk, VMRI is more volatile compared to SCTQ. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, FRIIF has a market cap of 79.44M. Regarding current trading prices, VMRI is priced at $0.00, while FRIIF trades at $12.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas FRIIF's P/E ratio is 6.38. In terms of profitability, VMRI's ROE is +0.00%, compared to FRIIF's ROE of +0.06%. Regarding short-term risk, VMRI is more volatile compared to FRIIF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, XAARF has a market cap of 76.54M. Regarding current trading prices, VMRI is priced at $0.00, while XAARF trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas XAARF's P/E ratio is -5.37. In terms of profitability, VMRI's ROE is +0.00%, compared to XAARF's ROE of -0.05%. Regarding short-term risk, VMRI is more volatile compared to XAARF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, INVE has a market cap of 74.50M. Regarding current trading prices, VMRI is priced at $0.00, while INVE trades at $3.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas INVE's P/E ratio is -2.77. In terms of profitability, VMRI's ROE is +0.00%, compared to INVE's ROE of +0.67%. Regarding short-term risk, VMRI is more volatile compared to INVE. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, QMCO has a market cap of 70.49M. Regarding current trading prices, VMRI is priced at $0.00, while QMCO trades at $10.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas QMCO's P/E ratio is -0.42. In terms of profitability, VMRI's ROE is +0.00%, compared to QMCO's ROE of +0.82%. Regarding short-term risk, VMRI is more volatile compared to QMCO. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, ALOT has a market cap of 67.98M. Regarding current trading prices, VMRI is priced at $0.00, while ALOT trades at $8.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas ALOT's P/E ratio is -4.65. In terms of profitability, VMRI's ROE is +0.00%, compared to ALOT's ROE of -0.17%. Regarding short-term risk, VMRI is more volatile compared to ALOT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, YIBO has a market cap of 67.08M. Regarding current trading prices, VMRI is priced at $0.00, while YIBO trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas YIBO's P/E ratio is 9.58. In terms of profitability, VMRI's ROE is +0.00%, compared to YIBO's ROE of +0.13%. Regarding short-term risk, VMRI is more volatile compared to YIBO. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, STRC has a market cap of 63.66M. Regarding current trading prices, VMRI is priced at $0.00, while STRC trades at $2.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas STRC's P/E ratio is -0.55. In terms of profitability, VMRI's ROE is +0.00%, compared to STRC's ROE of +0.00%. Regarding short-term risk, VMRI is more volatile compared to STRC. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, TBIIF has a market cap of 62.63M. Regarding current trading prices, VMRI is priced at $0.00, while TBIIF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas TBIIF's P/E ratio is -2.98. In terms of profitability, VMRI's ROE is +0.00%, compared to TBIIF's ROE of -0.28%. Regarding short-term risk, VMRI is more volatile compared to TBIIF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, OSS has a market cap of 56.35M. Regarding current trading prices, VMRI is priced at $0.00, while OSS trades at $2.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas OSS's P/E ratio is -4.02. In terms of profitability, VMRI's ROE is +0.00%, compared to OSS's ROE of -0.41%. Regarding short-term risk, VMRI is more volatile compared to OSS. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, TAKOF has a market cap of 50.08M. Regarding current trading prices, VMRI is priced at $0.00, while TAKOF trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas TAKOF's P/E ratio is -3.53. In terms of profitability, VMRI's ROE is +0.00%, compared to TAKOF's ROE of -1.04%. Regarding short-term risk, VMRI is more volatile compared to TAKOF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CREAF has a market cap of 47.87M. Regarding current trading prices, VMRI is priced at $0.00, while CREAF trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CREAF's P/E ratio is -3.78. In terms of profitability, VMRI's ROE is +0.00%, compared to CREAF's ROE of -0.20%. Regarding short-term risk, VMRI is more volatile compared to CREAF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, TACT has a market cap of 35.48M. Regarding current trading prices, VMRI is priced at $0.00, while TACT trades at $3.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas TACT's P/E ratio is -3.56. In terms of profitability, VMRI's ROE is +0.00%, compared to TACT's ROE of -0.27%. Regarding short-term risk, VMRI is more volatile compared to TACT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, FATH has a market cap of 34.68M. Regarding current trading prices, VMRI is priced at $0.00, while FATH trades at $5.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas FATH's P/E ratio is 2.15. In terms of profitability, VMRI's ROE is +0.00%, compared to FATH's ROE of +0.04%. Regarding short-term risk, VMRI is more volatile compared to FATH. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, AOTOF has a market cap of 33.07M. Regarding current trading prices, VMRI is priced at $0.00, while AOTOF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas AOTOF's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to AOTOF's ROE of -0.45%. Regarding short-term risk, VMRI is more volatile compared to AOTOF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, PRWYF has a market cap of 31.02M. Regarding current trading prices, VMRI is priced at $0.00, while PRWYF trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas PRWYF's P/E ratio is -1.67. In terms of profitability, VMRI's ROE is +0.00%, compared to PRWYF's ROE of +0.02%. Regarding short-term risk, VMRI is more volatile compared to PRWYF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, KTCC has a market cap of 26.26M. Regarding current trading prices, VMRI is priced at $0.00, while KTCC trades at $2.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas KTCC's P/E ratio is -3.30. In terms of profitability, VMRI's ROE is +0.00%, compared to KTCC's ROE of -0.06%. Regarding short-term risk, VMRI is more volatile compared to KTCC. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, EBON has a market cap of 24.93M. Regarding current trading prices, VMRI is priced at $0.00, while EBON trades at $3.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas EBON's P/E ratio is -1.18. In terms of profitability, VMRI's ROE is +0.00%, compared to EBON's ROE of -0.13%. Regarding short-term risk, VMRI is more volatile compared to EBON. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, AITX has a market cap of 21.25M. Regarding current trading prices, VMRI is priced at $0.00, while AITX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas AITX's P/E ratio is -0.15. In terms of profitability, VMRI's ROE is +0.00%, compared to AITX's ROE of +0.43%. Regarding short-term risk, VMRI is more volatile compared to AITX. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SGE has a market cap of 12.27M. Regarding current trading prices, VMRI is priced at $0.00, while SGE trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SGE's P/E ratio is 2.98. In terms of profitability, VMRI's ROE is +0.00%, compared to SGE's ROE of +0.34%. Regarding short-term risk, VMRI is more volatile compared to SGE. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, UAVS has a market cap of 11.60M. Regarding current trading prices, VMRI is priced at $0.00, while UAVS trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas UAVS's P/E ratio is -0.02. In terms of profitability, VMRI's ROE is +0.00%, compared to UAVS's ROE of -7.96%. Regarding short-term risk, VMRI is more volatile compared to UAVS. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, VLD has a market cap of 11.04M. Regarding current trading prices, VMRI is priced at $0.00, while VLD trades at $1.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas VLD's P/E ratio is -0.08. In terms of profitability, VMRI's ROE is +0.00%, compared to VLD's ROE of -2.19%. Regarding short-term risk, VMRI is more volatile compared to VLD. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SCKT has a market cap of 10.18M. Regarding current trading prices, VMRI is priced at $0.00, while SCKT trades at $1.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SCKT's P/E ratio is -3.56. In terms of profitability, VMRI's ROE is +0.00%, compared to SCKT's ROE of -0.15%. Regarding short-term risk, VMRI is more volatile compared to SCKT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, EVRC has a market cap of 9.76M. Regarding current trading prices, VMRI is priced at $0.00, while EVRC trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas EVRC's P/E ratio is 10.00. In terms of profitability, VMRI's ROE is +0.00%, compared to EVRC's ROE of +0.02%. Regarding short-term risk, VMRI is more volatile compared to EVRC. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, VJET has a market cap of 5.85M. Regarding current trading prices, VMRI is priced at $0.00, while VJET trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas VJET's P/E ratio is -0.57. In terms of profitability, VMRI's ROE is +0.00%, compared to VJET's ROE of -0.43%. Regarding short-term risk, VMRI is more volatile compared to VJET. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CCUR has a market cap of 5.53M. Regarding current trading prices, VMRI is priced at $0.00, while CCUR trades at $1,876.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CCUR's P/E ratio is -4.69. In terms of profitability, VMRI's ROE is +0.00%, compared to CCUR's ROE of +0.00%. Regarding short-term risk, VMRI is more volatile compared to CCUR. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, VIDE has a market cap of 4.70M. Regarding current trading prices, VMRI is priced at $0.00, while VIDE trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas VIDE's P/E ratio is -40.00. In terms of profitability, VMRI's ROE is +0.00%, compared to VIDE's ROE of +0.61%. Regarding short-term risk, VMRI is more volatile compared to VIDE. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, VRTK has a market cap of 3.49M. Regarding current trading prices, VMRI is priced at $0.00, while VRTK trades at $1.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas VRTK's P/E ratio is 18.20. In terms of profitability, VMRI's ROE is +0.00%, compared to VRTK's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to VRTK. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, FNTTF has a market cap of 2.76M. Regarding current trading prices, VMRI is priced at $0.00, while FNTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas FNTTF's P/E ratio is -0.91. In terms of profitability, VMRI's ROE is +0.00%, compared to FNTTF's ROE of +0.58%. Regarding short-term risk, VMRI is more volatile compared to FNTTF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, TKSTF has a market cap of 2.04M. Regarding current trading prices, VMRI is priced at $0.00, while TKSTF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas TKSTF's P/E ratio is -4.10. In terms of profitability, VMRI's ROE is +0.00%, compared to TKSTF's ROE of +0.06%. Regarding short-term risk, VMRI is more volatile compared to TKSTF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, STRCW has a market cap of 1.29M. Regarding current trading prices, VMRI is priced at $0.00, while STRCW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas STRCW's P/E ratio is -0.06. In terms of profitability, VMRI's ROE is +0.00%, compared to STRCW's ROE of +0.00%. Regarding short-term risk, VMRI is more volatile compared to STRCW. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, JLMKF has a market cap of 919322.00. Regarding current trading prices, VMRI is priced at $0.00, while JLMKF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas JLMKF's P/E ratio is -0.15. In terms of profitability, VMRI's ROE is +0.00%, compared to JLMKF's ROE of -1.62%. Regarding short-term risk, VMRI is more volatile compared to JLMKF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, YRLLF has a market cap of 632116.00. Regarding current trading prices, VMRI is priced at $0.00, while YRLLF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas YRLLF's P/E ratio is -3.37. In terms of profitability, VMRI's ROE is +0.00%, compared to YRLLF's ROE of +0.09%. Regarding short-term risk, VMRI is more volatile compared to YRLLF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, ITOX has a market cap of 560315.00. Regarding current trading prices, VMRI is priced at $0.00, while ITOX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas ITOX's P/E ratio is -0.10. In terms of profitability, VMRI's ROE is +0.00%, compared to ITOX's ROE of +0.56%. Regarding short-term risk, VMRI is more volatile compared to ITOX. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, DDDX has a market cap of 504152.00. Regarding current trading prices, VMRI is priced at $0.00, while DDDX trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas DDDX's P/E ratio is -0.58. In terms of profitability, VMRI's ROE is +0.00%, compared to DDDX's ROE of +0.14%. Regarding short-term risk, VMRI is more volatile compared to DDDX. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CRTG has a market cap of 215843.00. Regarding current trading prices, VMRI is priced at $0.00, while CRTG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CRTG's P/E ratio is -0.06. In terms of profitability, VMRI's ROE is +0.00%, compared to CRTG's ROE of +5.53%. Regarding short-term risk, VMRI is more volatile compared to CRTG. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, DWDZF has a market cap of 204960.00. Regarding current trading prices, VMRI is priced at $0.00, while DWDZF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas DWDZF's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to DWDZF's ROE of +0.66%. Regarding short-term risk, VMRI and DWDZF have similar daily volatility (196.04).

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, HAUP has a market cap of 123488.00. Regarding current trading prices, VMRI is priced at $0.00, while HAUP trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas HAUP's P/E ratio is -0.12. In terms of profitability, VMRI's ROE is +0.00%, compared to HAUP's ROE of +92.50%. Regarding short-term risk, VMRI is more volatile compared to HAUP. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, GOSY has a market cap of 82500.00. Regarding current trading prices, VMRI is priced at $0.00, while GOSY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas GOSY's P/E ratio is -0.10. In terms of profitability, VMRI's ROE is +0.00%, compared to GOSY's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to GOSY. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, EUOT has a market cap of 47963.00. Regarding current trading prices, VMRI is priced at $0.00, while EUOT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas EUOT's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to EUOT's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to EUOT. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, RDRSF has a market cap of 17721.00. Regarding current trading prices, VMRI is priced at $0.00, while RDRSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas RDRSF's P/E ratio is -0.01. In terms of profitability, VMRI's ROE is +0.00%, compared to RDRSF's ROE of +2.09%. Regarding short-term risk, VMRI and RDRSF have similar daily volatility (196.04).

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SNIOF has a market cap of 11252.00. Regarding current trading prices, VMRI is priced at $0.00, while SNIOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SNIOF's P/E ratio is -0.00. In terms of profitability, VMRI's ROE is +0.00%, compared to SNIOF's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to SNIOF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, NADA has a market cap of 10437.00. Regarding current trading prices, VMRI is priced at $0.00, while NADA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas NADA's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to NADA's ROE of N/A. Regarding short-term risk, VMRI and NADA have similar daily volatility (196.04).

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, CBEX has a market cap of 2343.00. Regarding current trading prices, VMRI is priced at $0.00, while CBEX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas CBEX's P/E ratio is 0.01. In terms of profitability, VMRI's ROE is +0.00%, compared to CBEX's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to CBEX. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, VOIS has a market cap of 1777.00. Regarding current trading prices, VMRI is priced at $0.00, while VOIS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas VOIS's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to VOIS's ROE of +0.00%. Regarding short-term risk, VMRI is more volatile compared to VOIS. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, MCZAF has a market cap of 735.00. Regarding current trading prices, VMRI is priced at $0.00, while MCZAF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas MCZAF's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to MCZAF's ROE of +0.00%. Regarding short-term risk, VMRI is more volatile compared to MCZAF. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, SOSO has a market cap of 389.00. Regarding current trading prices, VMRI is priced at $0.00, while SOSO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas SOSO's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to SOSO's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to SOSO. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, MDEA has a market cap of 132.00. Regarding current trading prices, VMRI is priced at $0.00, while MDEA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas MDEA's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to MDEA's ROE of N/A. Regarding short-term risk, VMRI is more volatile compared to MDEA. This indicates potentially higher risk in terms of short-term price fluctuations for VMRI.

VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VMRI stands at 6957.00. In comparison, IWRS comparison data is unavailable. Regarding current trading prices, VMRI is priced at $0.00, while IWRS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VMRI currently has a P/E ratio of N/A, whereas IWRS's P/E ratio is N/A. In terms of profitability, VMRI's ROE is +0.00%, compared to IWRS's ROE of N/A. Regarding short-term risk, VMRI and IWRS have similar daily volatility (196.04).